• Ranitidine cancer risk. Recall of ranitidine drug/
    Advice for patients,  Pharmacy insights

    Ranitidine Cancer RISK: why was ranitidine recalled?

    Ranitidine and cancer risk: a scary thought for many patients. Global market for ranitidine has been in turmoil in recent months, due to number of ranitidine recalls (including branded Zantac) by The U.S. Food and Drug Administration (FDA) in the US and shortly afterward, in UK. The Medicines and Healthcare Regulatory Agency (MHRA) recalled number of ranitidine products due to possible contamination with N-nitrosodimethylamine (NDMA), which has genotoxic and carcinogenic potential, a substance that could possibly cause cancer. Ranitidine – cancer scare was born. Note: Ranitidine (the chemical) does not have carcinogenic potential, but NDMA, a contaminant, which was found in many ranitidine containing products (tablets). Ranitidine is a commonly…

  • Ranitidine vs Omeprazole can you take both drugs together?
    Advice for patients

    Ranitidine vs Omeprazole: which drug is better?

    After my recent post on Omeprazole’s alternative drugs, I want to stay in the subject of gastro-oesophageal reflux disease (GORD) and its treatment. In this post, I will contrast Ranitidine vs Omeprazole and briefly discuss: the differences between both classes of drugs (mechanism of action) the effectiveness of Ranitidine vs Omeprazole their safety (contrast of possible side effects) use of Ranitidine and Omeprazole together at the same time Ranitidine vs Omeprazole: Mechanism of action Ranitidine and Omeprazole belong to different classes of drugs, both used in the treatment of heartburn/indigestion. Ranitidine is classified as an h2 receptor antagonist, commonly named h2 blockers. Omeprazole belongs to a group of drugs called proton pump inhibitors (PPIs). The…